Aduhelm is FDA Approved for Alzheimer's, But Does it Work?

The video discusses the FDA's approval of a new Alzheimer's drug, highlighting the controversy surrounding its efficacy and cost. While the drug reduces brain plaques, its impact on disease progression is unclear. The approval has sparked debate among experts, with concerns about side effects and financial burden on Medicare. The FDA requires further trials, and a federal investigation into the approval process is underway.

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF